D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.3% |
| 4 | Financials | 9.14% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
First American
FAF
$7.8B
| $24.7M | 0.03% |
477,342
-106,722
| -18% | -$5.69M |
|
|
GLUU
602
DELISTED
Glu Mobile Inc.
GLUU
| $24.6M | 0.03% |
3,843,285
-336,000
| -8% | -$1.75M |
|
603
Coeur Mining
CDE
$15.8B
| $24.5M | 0.03% |
3,224,761
+117,342
| +4% | +$947K |
|
|
604
CALL
Meta Platforms (Facebook)
META
$1.53T
| $24.3M | 0.03% |
+125,000
| New | +$22.6M |
|
|
NCI
605
DELISTED
Navigant Consulting, Inc.
NCI
| $24.3M | 0.03% |
1,095,797
+139,953
| +15% | +$3.18M |
|
|
DNB
606
DELISTED
Dun & Bradstreet
DNB
| $24.2M | 0.03% |
197,306
-40,564
| -17% | -$4.94M |
|
607
Philip Morris
PM
$301B
| $24.2M | 0.03% |
299,584
+267,858
| +844% | +$22.7M |
|
608
Arch Capital
ACGL
$36.4B
| $24M | 0.03% |
905,764
+278,914
| +44% | +$7.49M |
|
609
Ameren
AEE
$31.3B
| $23.9M | 0.03% |
393,290
+67,080
| +21% | +$3.86M |
|
|
610
CALL
Merck
MRK
$323B
| $23.8M | 0.03% |
411,654
-7,756
| -2% | -$438K |
|
611
Dell
DELL
$288B
| $23.8M | 0.03% |
1,001,779
-327,387
| -25% | -$7.23M |
|
612
Bio-Rad Laboratories Class A
BIO
$8.36B
| $23.7M | 0.03% |
82,237
-27,327
| -25% | -$7.55M |
|
|
DNR
613
DELISTED
Denbury Resources, Inc.
DNR
| $23.7M | 0.03% |
4,930,093
-1,457,980
| -23% | -$5.47M |
|
614
Sanmina
SANM
$11.4B
| $23.7M | 0.03% |
808,898
+145,864
| +22% | +$4.29M |
|
615
PUT
Altria Group
MO
$121B
| $23.7M | 0.03% |
416,600
+152,900
| +58% | +$8.82M |
|
616
CALL
Teva Pharmaceuticals
TEVA
$36.1B
| $23.6M | 0.03% |
971,400
+297,800
| +44% | +$6.07M |
|
617
UGI
UGI
$7.97B
| $23.6M | 0.03% |
452,348
-151,087
| -25% | -$7.32M |
|
618
MKS Inc
MKSI
$22.3B
| $23.5M | 0.03% |
246,061
+219,045
| +811% | +$23.9M |
|
619
Aon
AON
$77.5B
| $23.5M | 0.03% |
171,293
+123,292
| +257% | +$17.4M |
|
|
BID
620
DELISTED
Sotheby's
BID
| $23.5M | 0.03% |
432,373
-47,338
| -10% | -$2.62M |
|
|
MRSH
621
Marsh
MRSH
$86.9B
| $23.5M | 0.03% |
286,151
+49,451
| +21% | +$4.04M |
|
622
ICICI Bank
IBN
$107B
| $23.4M | 0.03% |
2,920,333
+2,741,830
| +1,536% | +$23.5M |
|
623
Weyerhaeuser
WY
$17.4B
| $23.4M | 0.03% |
642,213
+632,694
| +6,647% | +$23.1M |
|
624
Insperity
NSP
$1.88B
| $23.3M | 0.03% |
245,000
-88,456
| -27% | -$7.61M |
|
625
Strategy Inc
MSTR
$34.4B
| $23.3M | 0.03% |
1,825,540
+111,300
| +6% | +$1.45M |
|
Similar funds
D.E. Shaw & Co's Q2 2018 Portfolio in Review
As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
- D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
- D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.